Independent
Tenure on this board
1.2 yrs
6 nominees · 4 ballot items.
Election of six directors; approval of amendment to decrease authorized common shares from 1,000,000,000 to 75,000,000; approval of amendment to conform exculpation provision to Delaware DGCL Section 102(b)(7); and ratification of Cherry Bekaert LLP as independent auditors for 2026.
Election of six directors (James Pawloski, Marc Deshusses, Richard Davis, Bradley Freels, Stephen McKnight, Charles Weiser) to serve until 2027 annual meeting.
Approve amendment to reduce authorized common stock from 1,000,000,000 to 75,000,000 shares; no change to par value or preferred stock; effective upon filing Certificate of Amendment.
This management proposal requests shareholder approval to reduce the number of authorized common shares from 1,000,000,000 to 75,000,000 via an amendment to the Certificate of Incorporation. Management frames the change as an administrative alignment following a prior 1-for-10 reverse stock split that materially reduced issued shares while leaving a large authorized share reserve; the Board argues that the current authorized level exceeds foreseeable needs and that a reduction will better align authorized capital with operational and strategic requirements and may reduce Delaware franchise tax exposure. Importantly, the proposal will not affect outstanding shares, par value, preferred stock authorization, stockholder rights, or listing on Nasdaq, and the Company expects the change to be effective upon filing the Certificate of Amendment. The Board recommends a FOR vote, citing alignment of capital structure, preservation of sufficient authorized shares for future financings and equity awards, and potential tax benefits. Shareholders should consider the practical impacts—this reduces the pool of shares available for future capital raises without further stockholder action (subject to regulatory/exchange requirements), which could constrain flexibility for financing or dilution mitigation strategies, but also decreases overhang that may be viewed positively by some investors. The transaction appears routine and non-controversial; however, in a tight financing market the smaller authorized pool could require more frequent shareholder approvals to increase authorization if necessary; conversely, the reduction may be interpreted by some investors as a signal management does not plan significant near-term dilution. Overall, the proposal is governance- and capitalization-focused, seeking to tidy the charter post-reverse-split while maintaining operational flexibility as represented by the Board's disclosure.
Approve amendment to restate Article EIGHT, Section A to limit director/officer monetary liability to the fullest extent permitted by DGCL Section 102(b)(7), with statutory carve-outs; effective upon filing Certificate of Amendment.
Ratify the Audit Committee’s appointment of Cherry Bekaert LLP as the Company’s independent auditors for 2026; approval is discretionary but recommended by Board.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 1.82% | 322,788 | $613K |
| 2 | CAPTRUST FINANCIAL ADVISORS | 1.17% | 206,738 | $393K |
| 3 | HAMILTON LANE ADVISORS LLC | 0.90% | 160,228 | $304K |
| 4 | D.A. DAVIDSON CO. | 0.84% | 148,179 | $282K |
| 5 | Icon Wealth Advisors, LLC | 0.61% | 108,361 | $206K |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 0.49% | 85,995 | $163K |
| 7 | BlackRock, Inc. | 0.45% | 79,283 | $151K |
| 8 | VANGUARD FIDUCIARY TRUST CO | 0.40% | 70,104 | $133K |
| 9 | RAYMOND JAMES FINANCIAL INC | 0.32% | 57,050 | $108K |
| 10 | Sigma Planning Corp | 0.31% | 55,553 | $106K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.